Cited by 197Alzheimer's disease research and treatmentsRadiopharmaceutical Chemistry and ApplicationsDementia and Cognitive Impairment Research

The DOI matches its Crossref record.

A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies

Zhang, Wei, Arteaga, Janna, Cashion, Daniel K., Chen, Gang, Gangadharmath, Umesh, Gomez, Luis F., Kasi, Dhanalakshmi, Lam, Chung, Liang, Qianwa, Liu, Changhui, Mocharla, Vani P., Mu, Fanrong, Sinha, Anjana, Szardenings, A. Katrin, Wang, Eric, Walsh, Joseph C., Xia, Chunfang, Yu, Chul, Zhao, Tieming, Kolb, Hartmuth C.·2012·Journal of Alzheimer's Disease

DOI 10.3233/jad-2012-120712

Open this paper in CoChat — free account

Abstract

Senile plaques and neurofibrillary tangles are prominent neuropathological hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents. While there are a number of amyloid-β positron emission tomography (PET) tracers currently in different stages of clinical development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates. In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compounds utilizing a unique screening process. A competitive autoradiography assay was set up to test compounds for binding to native tau tangles and amyloid-β plaques on human brain tissue sections. In our in vitro assays, the 18F labeled compound [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains. Our in vitro and preclinical in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.

Integrity signals

Registry

Crossref · 10.3233/jad-2012-120712

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 101–197 of 197

Thiophene‐Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic‐Disease‐Associated Protein Aggregates
Björk, L., Klingstedt, T., & Nilsson, K. P. R. (2023) · ChemBioChem · doi:10.1002/cbic.202300044 · Cited by 24
Brain [18F]FDDNP Binding and Glucose Metabolism in Advanced Elderly Healthy Subjects and Alzheimer's Disease Patients
Tauber, C., Beaufils, É., Hommet, C., Ribeiro, M. J., Vercouillie, J., Vierron, E., Mondon, K., Cottier, J., Gissot, V., Guilloteau, D., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122068 · Cited by 23
Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations
Cummings, J. L., & Zhong, K. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.205 · Cited by 21
Alzheimer’s Dementia: The Emerging Role of Positron Emission Tomography
Tripathi, S. M., & Murray, A. D. (2021) · The Neuroscientist · doi:10.1177/1073858421997035 · Cited by 23
Harnessing the Immune System for Treatment and Detection of Tau Pathology
Congdon, E. E., Krishnaswamy, S., & Sigurdsson, E. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132435 · Cited by 20
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Todarwal, Y., Gustafsson, C., Minh, N. N. T., Ertzgaard, I., Klingstedt, T., Ghetti, B. F., Vidal, R., König, C., Lindgren, M., Nilsson, K. P. R., et al. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c06019 · Cited by 20
Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
Zhang, S., Dong, H., Bian, J., Li, D., & Liu, C. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.10.009 · Cited by 23
Self-citation
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals
Klenner, M. A., Pascali, G., Fraser, B. H., & Darwish, T. A. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2021.03.011 · Cited by 18
Tau PET Imaging
Higuchi, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_18 · Cited by 20
Benzo[4,5]imidazo[1,2- a ]pyridines and benzo[4,5]imidazo[1,2- a ]pyrimidines: recent advancements in synthesis of two diversely important heterocyclic motifs and their derivatives
Debnath, S., Parveen, S., Pradhan, P., Das, I., & Das, T. (2022) · New Journal of Chemistry · doi:10.1039/d2nj00546h · Cited by 18
Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies
Choi, Y., Ha, S., Lee, Y., Kim, Y. K., Lee, D. S., & Kim, D. J. (2017) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-017-0484-7 · Cited by 18
DMAP‐Catalyzed C—N Bond Formation for Diverse Synthesis of Imidazo[1,2‐a]pyrimidine and Pyrimido[1,2‐a]benzimidazole Derivatives
Shang, L. Q., Feng, Y., Gao, X., Chen, Z., Xia, Y., Jin, W., & Liu, C. (2020) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202000214 · Cited by 17
Self-citation
AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention
Meyer, P., McSweeney, M., Gonneaud, J., & Villeneuve, S. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.001 · Cited by 20
Coordination chemistry of ligands: Insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer’s disease
Selvan, S. T., Ravichandar, R., Ghosh, K. K., Mohan, A., Mahalakshmi, P., Gulyás, B. Z., & Padmanabhan, P. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213659 · Cited by 16
Towards pharmacological prevention of Alzheimer disease
Llibre‐Guerra, J. J., McDade, E., Schindler, S. E., Clifford, D. B., Supnet, C. B., Atri, A., & Bateman, R. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01154-y · Cited by 18
Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy
Sahara, N., Maeda, J., Ishikawa, A., Tokunaga, M., Suhara, T., & Higuchi, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179933 · Cited by 16
General Aspects of Organofluorine Compounds
Reddy, V. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53748-5.00001-0 · Cited by 15
Benzo[4,5]imidazole[2,1-b]quinazoline-1(2H)-one: An efficient fluorescent probe for the selective and sensitive detection of Cu(II) ions
Roja, S. S., Sunil, P. S., Darussalam, M. M., Manoharan, V., Prakash, J., & Kumar, R. R. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.125853 · Cited by 14
Synthesis and Preclinical Evaluation of 2-(4-[ 18 F]Fluorophenyl)imidazo[1,2-h][1,7]naphthyridine ([ 18 F]FPND-4): An Aza-Fused Tricyclic Derivative as Positron Emission Tomography Tracer for Neurofibrillary Tangle Imaging
Liu, T., Li, Y., Zhang, X., Yao, A., Wang, Y., Yao, S., Chen, B., Yan, X., Dai, J., Zhang, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00239 · Cited by 14
Synthesis and Evaluation of 13N-Labelled Azo Compounds for β-Amyloid Imaging in Mice
Gaja, V., Gómez‐Vallejo, V., Puigivila, M., Pérez‐Campaña, C., Martín, A., García‐Osta, A., Calvo-Fernández, T., Cuadrado‐Tejedor, M., Franco, R., & Llop, J. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0708-x · Cited by 14
AD molecular: Imaging tau aggregates with positron emissions tomography
Betthauser, T. J. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.007 · Cited by 14
Phosphoramidates as Steering Elements for Highly Selective Access to Complementary Imidazo[1,2-a]pyrimidine Isomers
White, N. A., Clagg, K., Sirois, L. E., Mack, K. A., Al-Sayah, M. A., Nack, W. A., O’Shea, P. D., Zhang, H., & Gosselin, F. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b03702 · Cited by 14
Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders
Mekala, S., Wu, Y., & Li, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00576g · Cited by 13
Biomarkers for the early diagnosis of Alzheimer's disease: The challenge of XXI century
Contino, M., Cantore, M., Leopoldo, M., & Colabufo, N. (2013) · Advances in Alzheimer s Disease · doi:10.4236/aad.2013.21003 · Cited by 16
The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease
Beaufils, É., Ribeiro, M. J., Vierron, E., Vercouillie, J., Dufour‐Rainfray, D., Cottier, J., Camus, V., Mondon, K., Guilloteau, D., & Hommet, C. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000363761 · Cited by 12
Synthesis of Substituted of Benzo[4,5]imidazo[1,2-a]pyrimidines through (3 + 2+1) Cyclization of 2-Aminobenzimidazole, Acetophenone, and N,N-Dimethylformamide as One-Carbon Synthon
Guo, M., Huang, X., Li, S., Ma, W., Liu, A., Zhang, X., Kuang, Q., Cheng, L., Song, Y., Hu, X., et al. (2023) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.3c01227 · Cited by 11
Synthesis of Naphthalene-Based Push-Pull Molecules with a Heteroaromatic Electron Acceptor
Šarlah, D., Juranovič, A., Kožar, B., Rejc, L., Golobič, A., & Petrič, A. (2016) · Molecules · doi:10.3390/molecules21030267 · Cited by 11
Molecular PET Imaging in Alzheimer’s Disease
Thientunyakit, T., Shiratori, S., Ishii, K., & Gelovani, J. G. (2022) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-022-00717-4 · Cited by 12
PET Radioligands for Imaging of Tau Pathology: Current Status
Choe, Y. S., & Lee, K.-H. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-015-0374-9 · Cited by 11
In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line
Sahara, N., Shimojo, M., Ono, M., Takuwa, H., Febo, M., Higuchi, M., & Suhara, T. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00663 · Cited by 11
Review—Electrochemical Strategies for Selective Fluorination of Organic Compounds
Thadathil, D. A., Varghese, A., & Radhakrishnan, K. V. (2021) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/ac148f · Cited by 11
Fluorine‐19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice
Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Kato, T., Hirao, K., Shirai, N., Sogabe, T., & Tooyama, I. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24188 · Cited by 11
An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer’s Disease Mouse Model
Snir, J. A., Suchý, M., Bindseil, G. A., Kovacs, M. S., Chronik, B. A., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170115 · Cited by 10
Recent development in selective Tau tracers for PET imaging in the brain
Li, Y., Liu, T., & Cui, M. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.03.024 · Cited by 10
Discovery and evaluation of aza-fused tricyclic derivatives for detection of Tau pathology in Alzheimer's disease
Liu, T., Li, Y., Wang, Y., Yan, X., Dai, J., & Cui, M. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114991 · Cited by 10
Coevolution of Atomic Resolution and Whole-Brain Imaging for Tau Neurofibrillary Tangles
Dalton, R. M., Krishnan, H. S., Parker, V. S., Catanese, M. C., & Hooker, J. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00426 · Cited by 10
Long-Term Dynamics of Ecosystem Services and Their Influencing Factors in Ecologically Fragile Southwest China
Ci, M., Ye, L., Liao, C., Yao, L., Tu, Z., Xing, Q., Tang, X., & Ding, Z. J. (2023) · Sustainability · doi:10.3390/su151612331 · Cited by 9
Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer’s Disease with Positron Emission Tomography
Xie, F., & Peng, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170280 · Cited by 8
A Biophysical Model of Shape Changes due to Atrophy in the Brain with Alzheimer’s Disease
Khanal, B., Lorenzi, M., Ayache, N., & Pennec, X. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-10470-6_6 · Cited by 8
A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease
Zhang, H., Zhu, F., Dodge, H. H., Higgins, G. A., Omenn, G. S., Guan, Y., & Initiative, T. A. D. N. (2018) · GigaScience · doi:10.1093/gigascience/giy085 · Cited by 7
Quantifying Water Provision Service Supply, Demand, and Spatial Flow in the Yellow River Basin
Liu, Y., Yang, Y., Wang, Z., & An, S. (2022) · Sustainability · doi:10.3390/su141610093 · Cited by 7
The first synthesis of [11C]J147, a new potential PET agent for imaging of Alzheimer’s disease
Wang, M., Gao, M., & Zheng, Q. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.031 · Cited by 7
Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes
Yang, F., Wang, K., Zhou, K., Dai, B., Dai, J., Liang, Y., & Cui, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.065 · Cited by 7
Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding
Bhuskute, K. R., Fan, J., & Kaur, A. (2025) · Aggregate · doi:10.1002/agt2.70133 · Cited by 6
Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
Li, S., & Bhalla, R. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04178-w · Cited by 8
Neuroimaging Biomarkers in Alzheimer’s Disease
Tripathi, S. M., Chutia, P., & Murray, A. D. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2040037 · Cited by 7
Evaluation of advanced, pathophysiologic new targets for imaging of CNS
Singh, P., Singh, D., Srivastava, P., Mishra, G., & Tiwari, A. K. (2023) · Drug Development Research · doi:10.1002/ddr.22040 · Cited by 5
Radiolabeled imaging agents for Alzheimer's disease
Wu, J., Li, K., Yang, J., Mao, M., & Cheng, Y. (2023) · iRadiology · doi:10.1002/ird3.35 · Cited by 5
From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease
Bolognesi, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12285-1 · Cited by 6
An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans
Huang, Y.-Y., Chiu, M., Yen, R., Tsai, C.-L., Hsieh, H.-Y., Chiu, C., Wu, C., Hsin, L., Tzen, K., Cheng, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217384 · Cited by 5
Sustainable Synthesis of Polyfluoro-Pyrimido [1,2-a] Benzimidazole Derivatives Using a Tandem Strategy─Ultrasound and an Integrated Continuous Flow System
Seenivasan, V. T., Chen, N., Govindan, K., Jayaram, A., Lin, Y.-C., Li, C., & Lin, W. (2025) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c03123 · Cited by 4
From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration
Giarratana, A. O. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1637243 · Cited by 4
Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease
Paterson, R. W., Toombs, J., Slattery, C. F., Schott, J. M., & Zetterberg, H. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0069-9 · Cited by 5
Efficient syntheses of benzo[4,5]imidazo[1,2-a]pyrimidine derivatives based on 2-aminobenzimidazole
Abbas, S. Y. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.145285 · Cited by 3
Recognition of GC base pairs of B-DNA by coumarin-based benzimidazopyrimidines
Sadhukhan, J., Mandal, P., Pramanik, S., Guria, S., Kabir, A. S., Das, D., & Adhikari, S. S. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob02055c · Cited by 3
A report of the automated radiosynthesis of the tau positron emission tomography radiopharmaceutical, [18F]‐THK‐5351
Neelamegam, R., Yokell, D. L., Rice, P. A., Furumoto, S., Kudo, Y., Okamura, N., & Fakhri, G. E. (2016) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3482 · Cited by 3
Distinct Heterocyclic Moieties Govern the Selectivity of Thiophene‐Vinylene‐Based Ligands towards Aβ or Tau Pathology in Alzheimer's Disease
Björk, L., Shirani, H., Todarwal, Y., Linares, M., Vidal, R., Ghetti, B. F., Norman, P., Klingstedt, T., & Nilsson, K. P. R. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300583 · Cited by 3
Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid‐β Deposits in Alzheimer's Disease
Wu, X., Shirani, H., Vidal, R., Ghetti, B. F., Ingelsson, M., Klingstedt, T., & Nilsson, K. P. R. (2024) · ChemistryOpen · doi:10.1002/open.202400186 · Cited by 2
Fluorine in Medicine
Yamaguchi, H. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839167591-00440 · Cited by 3
Reporters of Amyloid Structural Polymorphism
LeVine, H., Nilsson, K. P. R., Nilsson, R., & Hammarström, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00007-9 · Cited by 3
Nonamyloid Pet Biomarkers and Alzheimer'S Disease: Current and Future Perspectives
Schilling, L. P., Leuzy, A., Zimmer, E. R., Gauthier, S. G., & Rosa‐Neto, P. (2014) · Future Neurology · doi:10.2217/fnl.14.40 · Cited by 4
Optimization and Biodistribution of [11C]-TKF, An Analog of Tau Protein Imaging Agent [18F]-THK523
Kong, Y., Guan, Y., Hua, F., Zhang, Z., Lu, X., Zhu, T., Zhao, B., Zhu, J., Li, C., & Chen, J. (2016) · Molecules · doi:10.3390/molecules21081019 · Cited by 3
Triphenylphosphine/Isocyanide Mediated Synthesis of Benzo[4,5]imidazo[1,2‐ a ]pyrimidine, Enamine Ketones and Secondary Ketimines
Shah, T. A., Raza, W., Muneer, M., Mir, N. A., & Ahmad, M. (2018) · ChemistrySelect · doi:10.1002/slct.201702724 · Cited by 3
Molecular Imaging in Neurology
Vallabhajosula, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-23205-3_15 · Cited by 2
A Cooperative Model for Symmetric Ligand Binding to Protein Fibrils
Smith, M. S., DeGrado, W. F., Grabe, M., & Shoichet, B. K. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00068 · Cited by 3
PET Tracers for Beta-Amyloid and Other Proteinopathies
Nordberg, A. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_8 · Cited by 2
Organofluorine Compounds as Positron Emission Tomography Tracers
Reddy, V. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53748-5.00007-1 · Cited by 2
Alzheimer’s Disease
Tam, J. H. K., & Pasternak, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00004-5 · Cited by 2
PET Imaging Agents for Alzheimer’s Disease
Choi, S., Plöessl, K., Zhu, L., & Kung, H. F. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_18 · Cited by 2
Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies
Varrone, A., Sousa, V. C., Mugnaini, M., Biesinger, S., Nordvall, G., Kingston, L. P., Guzzetti, I., Elmore, C. S., Sunnemark, D., Guarino, D. S., et al. (2025) · Cells · doi:10.3390/cells14120869 · Cited by 1
Breaking the Alzheimer’s Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents
Gao, H., Cheng, F., Zhang, Z., Yan, B., Liao, P., Zhang, S., Li, D., Chen, F., & Lei, P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05320-7 · Cited by 1
Chronic traumatic encephalopathy
Gardner, R. C., & Perry, D. C. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.024 · Cited by 1
Heterocyclization Reactions of Imidazo[1,2-a]pyrimidine Analogues (A Review)
He, L., Liu, J., Zhao, H. L., & Kang, C. M. (2023) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428023130031 · Cited by 1
Specific chemical determinants are central for achieving ligands for selective detection of amyloid-β deposits in Alzheimer’s disease
Mousavi, M., Klingstedt, T., Carrasco‐Busturia, D., Vidal, R., Ghetti, B. F., Linares, M., Norman, P., & Nilsson, K. P. R. (2025) · Australian Journal of Chemistry · doi:10.1071/ch25095 · Cited by 1
2-(4-(2-[18F]Fluoroethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine
Leung, K. (2012) · Europe PMC (PubMed Central) · Cited by 1
Tau and beta-amyloid deposition, structural integrity, and cognitive function following traumatic brain injury in Australian war veterans
Cummins, T. L. (2018) · Minerva Access (University of Melbourne) · Cited by 1
Developing Targeted PET Tracers in the Era of Personalized Medicine
Bohorquez, S. M. S., van Bruggen, N., & Mařı́k, J. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677252.ch12
Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease
Malmsten, L. (2014) · Figshare
Diagnostica per immagini cerebrale tramite tomografia a emissione di positroni in neurologia: dalla misurazione del flusso sanguigno e del metabolismo all’esplorazione della neurotrasmissione
Hammers, A. (2015) · EMC - Neurologia · doi:10.1016/s1634-7072(15)70502-7
Markers of Prognosis in Neurodegenerative Dementia
Stubendorff, K. (2014) · Lund University Publications (Lund University)
OPINION Neuroimaging insights into network-based neurodegeneration
Greicius, M. D., & Kimmel, D. L. (2012)
Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma Implications for Alzheimer's disease
Pannee, J. (2015)
PET Imaging of Pathological Tau in Progressive Supranuclear Palsy
Coakeley, S. (2016) · TSpace (University of Toronto)
Advanced Drug Discovery for Alzheimer’s Disease: Challenges and Strategies
Haque, R., & Nazir, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-5187-6_2
Associations of Amyloid Deposition and FDG Uptake in Aging and Cognitively Impaired Elders With and Without Moderate to Severe Periventricular White Matter Hyperintensities Using Simple Machine Learning Techniques
Zukotynski, K. (2020) · TSpace (University of Toronto)
Imaging of FTLD-tau Using [18F]AV-1451
Burke, C. (2017) · TSpace (University of Toronto)
Author Index Volume 31 (2012)
(2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-31422
Introduction
Liu, S. (2017) · Springer theses · doi:10.1007/978-981-10-3533-3_1
Faculty Opinions recommendation of Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
Perani, D. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718113640.793484091
Faculty Opinions recommendation of Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725773166.793537454
Densité des dépôts de la protéine Tau versus activité métabolique cortico-cérébrale chez des patients atteints de maladie d’Alzheimer ou de pathologies apparentées
Pasquesoone, H., Vercouillie, J., Balageas, A., Gissot, V., Dupont, A.-C., Arlicot, N., Maia, S., Beaufils, É., & Ribeiro, M. J. (2022) · Médecine Nucléaire · doi:10.1016/j.mednuc.2022.05.001
PROGRESS IN IDENTIFYING BINDERS TO DISEASE-RELEVANT TAU AND α-SYNUCLEIN WITH THERAPEUTIC OR DIAGNOSTIC POTENTIAL
Capacci, A. G., & Paras, N. A. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch02
I2-DMSO-Mediated Three-Component Cyclization of 2-Aminobenzimidazole to Access 2,3-Substituted Benzo[4,5]imidazo[1,2-a]pyrimidine Derivatives
Guo, M., Guo, Q., Yuan, W., Liao, S., Cheng, L., & Yuan, J. (2025) · Synthesis · doi:10.1055/a-2631-4457
The importance of tau tracers in the diagnosis of neurodegenerative diseases
Sadeghian, S., & Seradj, S. H. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103531
One-pot synthesis of pyrimido[1,2- a ]benzimidazoles using calcium carbide as an acetylene source
Liu, C., An, R., Gu, P., & Wei, M. (2026) · Organic Chemistry Frontiers · doi:10.1039/d6qo00446f
Self-citation
BindingDB Entry 50040819: Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.
BindingDB (2013) · UC San Diego · doi:10.7270/q2z320tv
BindingDB Entry 50040674: Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils andß-amyloid plaques in Alzheimer's disease models.
BindingDB (2013) · UC San Diego · doi:10.7270/q2pc33hq

Authors: Zhang, W., Arteaga, J., Cashion, D. K., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., Mocharla, V. P., Mu, F., Sinha, A., Szardenings, A. K., Wang, E., Walsh, J. C., Xia, C., Yu, C., Zhao, T., & Kolb, H. C.
Affiliations: Siemens Molecular Imaging, Inc., Culver City, CA, USA
Corresponding author: Kolb, Hartmuth C.
ORCID: Zhang, Wei
Liang, Qianwa
Liu, Changhui
Szardenings, A. Katrin
Kolb, Hartmuth C.
Venue: Journal of Alzheimer's Disease
Publisher: SAGE Publications
Published: 2012-08-22
Volume: 31
Issue: 3
Pages: 601-612
ISSN: 1387-2877 (ISSN-L)
1875-8908
DOI: 10.3233/jad-2012-120712
OpenAlex: W2152648555
Cited by: 195
References: 0
Citations by year: 2026: 3 · 2025: 13 · 2024: 4 · 2023: 12 · 2022: 12 · 2021: 7 · 2020: 6 · 2019: 11 · 2018: 13 · 2017: 18 · 2016: 18 · 2015: 21 · 2014: 25 · 2013: 23 · 2012: 9
FWCI: 17.08
Type: journal article
Language: en
Open access: closed
Locations: Journal of Alzheimer s Disease (publishedVersion)
PubMed (publishedVersion)
Funders: Siemens Medical Solutions USA
National Institute on Aging
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: tau PET tracers
MeSH terms: Animals, Autoradiography, Fluorine Radioisotopes, Humans, Mice, Inbred ICR, Protein Binding, Amyloid beta-Peptides, tau Proteins, Rats, Sprague-Dawley, Radiopharmaceuticals, Positron-Emission Tomography, Mice, Rats, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks